Investing IdeasBrowse All StocksMarkets
Have your own idea? Try our Stock Screener
Header cover image

U.S. Personal Products Industry Analysis

UpdatedJan 20, 2026
DataAggregated Company Financials
Companies116
  • 7D1.5%
  • 3M5.8%
  • 1Y-4.9%
  • YTD4.4%

Over the last 7 days, the Personal Products industry has risen 1.5%, driven by gains from Kenvue of 1.1%. In contrast, the industry has lost 4.9% in the last 12 months. As for the next few years, earnings are expected to grow by 34% per annum.

Industry Valuation and Performance

Has the U.S. Personal Products Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Tue, 20 Jan 2026US$94.2bUS$47.6bUS$350.2m22.5x269.1x2x
Thu, 18 Dec 2025US$90.1bUS$47.6bUS$351.6m23.1x256.2x1.9x
Sat, 15 Nov 2025US$83.8bUS$47.5bUS$512.4m21.5x163.5x1.8x
Mon, 13 Oct 2025US$88.4bUS$47.7bUS$307.9m20.5x287x1.9x
Wed, 10 Sep 2025US$97.0bUS$47.6bUS$304.1m22.8x318.9x2x
Fri, 08 Aug 2025US$99.1bUS$48.0bUS$93.7m23.4x1057.4x2.1x
Sun, 06 Jul 2025US$101.5bUS$48.0bUS$109.4m18.9x927.8x2.1x
Tue, 03 Jun 2025US$97.7bUS$48.0bUS$127.4m17.1x766.9x2x
Thu, 01 May 2025US$88.5bUS$48.6bUS$540.5m21.2x163.7x1.8x
Sat, 29 Mar 2025US$91.8bUS$48.7bUS$511.0m23.6x179.6x1.9x
Mon, 24 Feb 2025US$95.1bUS$48.9bUS$313.7m26.7x303x1.9x
Wed, 22 Jan 2025US$97.9bUS$49.3bUS$1.5b26.8x66.4x2x
Fri, 20 Dec 2024US$98.2bUS$49.3bUS$1.5b27.7x66.6x2x
Sun, 17 Nov 2024US$98.0bUS$49.3bUS$1.5b26.5x66.8x2x
Tue, 15 Oct 2024US$106.9bUS$49.5bUS$1.6b26.6x66.1x2.2x
Thu, 12 Sep 2024US$105.8bUS$49.5bUS$1.6b20.7x64.6x2.1x
Sat, 10 Aug 2024US$110.0bUS$49.2bUS$1.9b23.1x59.4x2.2x
Mon, 08 Jul 2024US$114.6bUS$49.0bUS$2.4b20.7x47.3x2.3x
Wed, 05 Jun 2024US$117.5bUS$49.0bUS$2.4b22.4x48.5x2.4x
Fri, 03 May 2024US$116.4bUS$48.7bUS$2.7b24.3x43.3x2.4x
Sun, 31 Mar 2024US$136.6bUS$48.8bUS$2.5b26.1x54.2x2.8x
Tue, 27 Feb 2024US$129.2bUS$49.0bUS$2.5b30.3x52x2.6x
Thu, 25 Jan 2024US$125.2bUS$50.1bUS$2.6b27.1x49x2.5x
Sat, 23 Dec 2023US$128.8bUS$49.9bUS$2.6b24.6x48.9x2.6x
Mon, 20 Nov 2023US$113.1bUS$50.0bUS$2.6b21.9x43.7x2.3x
Wed, 18 Oct 2023US$119.0bUS$50.0bUS$3.3b22.8x36.3x2.4x
Fri, 15 Sep 2023US$129.7bUS$50.0bUS$3.3b19.8x39.6x2.6x
Sun, 13 Aug 2023US$141.0bUS$49.8bUS$3.1b20.1x46.2x2.8x
Tue, 11 Jul 2023US$151.4bUS$49.3bUS$3.1b22x48.3x3.1x
Thu, 08 Jun 2023US$146.8bUS$49.3bUS$3.1b22.8x46.9x3x
Sat, 06 May 2023US$155.6bUS$48.8bUS$3.3b21x46.7x3.2x
Mon, 03 Apr 2023US$121.4bUS$34.6bUS$1.6b18x76.3x3.5x
Wed, 01 Mar 2023US$119.4bUS$34.7bUS$1.4b18.7x83.5x3.4x
Fri, 27 Jan 2023US$127.9bUS$35.9bUS$2.1b19.3x61.9x3.6x
Price to Earnings Ratio

61.9x


Total Market Cap: US$127.9bTotal Earnings: US$2.1bTotal Revenue: US$35.9bTotal Market Cap vs Earnings and Revenue0%0%0%
U.S. Personal Products Industry Price to Earnings3Y Average 163x202420252026
Current Industry PE
  • Investors are optimistic on the American Personal Products industry, and appear confident in long term growth rates.
  • The industry is trading at a PE ratio of 269x which is higher than its 3-year average PE of 163x.
  • The 3-year average PS ratio of 2.4x is higher than the industry's current PS ratio of 2.0x.
Past Earnings Growth
  • The earnings for companies in the Personal Products industry have declined 45% per year over the last three years.
  • Meanwhile revenues for these companies have grown 9.9% per year.
  • This means that although more sales are being generated, either the cost of doing business or the level of investment back into businesses has increased, which has decreased profits.

Industry Trends

Which industries have driven the changes within the U.S. Consumer Staples industry?

US Market-0.55%
Consumer Staples1.78%
Personal Products1.45%
Personal Products1.45%
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
KVUE KenvueUS$17.201.1%
+US$364.0m		-17.3%PE23x
ELF e.l.f. BeautyUS$89.992.8%
+US$144.9m		-24.1%PE65.6x
HLF HerbalifeUS$16.978.7%
+US$140.5m		157.9%PE5.5x
BRBR BellRing BrandsUS$23.913.6%
+US$98.3m		-68.5%PE13.1x
ODD Oddity TechUS$35.404.7%
+US$91.3m		-21.4%PE18.5x

Latest News

ELF
US$89.99
e.l.f. Beauty
7D
2.8%
1Y
-24.1%

ELF: Market Share Gains And Shipment Normalization Will Support Future Upside

Analysts have trimmed their price targets on e.l.f. Beauty, nudging the fair value estimate down by about $2 to $113.77 per share. They are factoring in slightly lower revenue growth assumptions, a modestly reduced future P/E multiple, and mixed Q2 results that included shipment timing headwinds alongside resilient underlying sales trends.
EL
US$115.05
Estée Lauder Companies
7D
-0.3%
1Y
46.0%

EL: Future Equity Overhang From Lockups Will Likely Pressure Shares

Analysts have raised their price target on Estée Lauder Companies to about US$74 from roughly US$65, citing updated assumptions that include a lower discount rate, higher projected revenue, a modestly higher profit margin and a slightly higher future P/E multiple. What's in the News Estée Lauder Companies and Jo Malone London launched the Jo Malone London Scent Advisor, an AI-powered digital tool that uses Google's Gemini and Vertex AI to recommend fragrances online through a conversational experience for US and UK customers on JoMalone.com (Product-Related Announcements).
NUS
US$11.54
Nu Skin Enterprises
7D
8.6%
1Y
57.7%

Nu Skin Enterprises, Inc.'s (NYSE:NUS) Share Price Could Signal Some Risk

Jan 17
Nu Skin Enterprises, Inc.'s (NYSE:NUS) Share Price Could Signal Some Risk
BRBR
US$23.91
BellRing Brands
7D
3.6%
1Y
-68.5%
COTY
US$3.05
Coty
7D
-4.4%
1Y
-58.2%
USNA
US$21.93
USANA Health Sciences
7D
8.0%
1Y
-36.2%
CABR
US$0.90
Caring Brands
7D
-3.7%
1Y
n/a
HLF
US$16.97
Herbalife
7D
8.7%
1Y
157.9%

HLF: Turnaround And Margin Recovery Under New Leadership Will Face Valuation Constraints

The analyst price target on Herbalife in our model has moved from US$12 to US$14, as analysts point to a recovery path supported by a healthier profit margin outlook, a slightly lower discount rate, and recent research highlighting ongoing business model improvements despite tempered revenue growth expectations and cautious sector valuations. Analyst Commentary Recent research on Herbalife reflects a mix of optimism about the company’s turnaround efforts and caution about broader sector and macro headwinds.
SKIN
US$1.50
Beauty Health
7D
-2.0%
1Y
-17.1%

SKIN: Future Returns Will Be Supported By Stable Margins And Completed Buyback Program

Analysts have modestly adjusted their price target on Beauty Health, citing small tweaks to the discount rate, revenue growth expectations, profit margin assumptions and forward P/E multiples. Together, these changes support a refined valuation framework rather than a major reset in outlook.
IPAR
US$89.93
Interparfums
7D
2.4%
1Y
-37.2%

IPAR: Asset Light Fragrance Focus Will Underpin Future Upside Potential

Narrative Update Analysts have kept the fair value estimate for Interparfums steady at about $103.60 per share. This reflects a balance between an $85 price target tied to ongoing operational challenges into 2026 and a $103 price target supported by views on the company’s focused fragrance exposure, asset light model, and current entry point.
KVUE
US$17.20
Kenvue
7D
1.1%
1Y
-17.3%

KVUE: Share Price Will Recover As Legal Overhangs Ease After Kimberly-Clark Deal

Narrative Update on Kenvue Analysts have kept their fair value estimate for Kenvue steady at $19.33 per share while making only slight adjustments to inputs like discount rate, revenue growth, profit margin and future P/E. This reflects mixed recent research that highlights cautious views around litigation and consumer headlines, alongside some optimism in Skin Health and Beauty and potential M&A interest.
OLPX
US$1.64
Olaplex Holdings
7D
-0.6%
1Y
4.5%

OLPX: Takeover Talks And Stable Margins Will Support Future Share Recovery

Narrative Update Analysts have modestly raised their fair value estimate for Olaplex Holdings to about $1.92 per share from roughly $1.89, reflecting updated assumptions on discount rate, profit margin, and future P/E. Street research includes a recent cut in one price target to $1.40 and an Equal Weight stance.
ODD
US$35.40
Oddity Tech
7D
4.7%
1Y
-21.4%

ODD: Beat And Raise Consistency Will Drive New Product Differentiation Phase

Analysts have trimmed their average price targets on Oddity Tech into a tighter US$46 to US$80 range. This reflects a mix of more cautious multiples tied to a softer U.S. backdrop, along with continued confidence in the company’s consistent execution, Q3 beat-and-raise pattern, and focus on product differentiation.
HNST
US$2.49
Honest Company
7D
-2.4%
1Y
-59.2%

HNST: Transformation 2.0 Execution Will Determine Upside From Depressed Expectations

Analysts have trimmed Honest Company's price target to US$3.00 from US$4.25, citing weaker than expected Q3 results, reduced full year guidance, and low visibility around the newly announced Transformation 2.0 plan. Analyst Commentary Bearish analysts have responded to Honest Company's recent update by trimming price targets and stressing that weak Q3 results and lower full year guidance add uncertainty to the story.
YSG
US$4.21
Yatsen Holding
7D
-6.7%
1Y
22.0%

YSG: Higher Margins And Q4 2025 Outlook Will Support Repricing

Analysts have lifted their price target for Yatsen Holding to reflect a higher fair value estimate, stronger profit margin assumptions, a richer future P/E, a slightly lower discount rate, and a modestly adjusted revenue growth outlook. What's in the News Yatsen Holding issued revenue guidance for the fourth quarter of 2025, indicating expected total net revenue between RMB 1.32b and RMB 1.49b (Key Developments).
BHST
US$4.88
BioHarvest Sciences
7D
-5.6%
1Y
-15.9%